Evidence map›Paper›PMID 36193329›Full record

ArticleBioMed research international2022

ZOMEC via the p-Akt/Nrf2 Pathway Restored PTZ-Induced Oxidative Stress-Mediated Memory Dysfunction in Mouse Model.

Rifat Jahan, Mohammad Yousaf, Hamayun Khan, Nousheen Bibi, Musarrat Ijaz, Touseef Rehan, Shahid Ali Shah

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Ranuncoside's attenuation of scopolamine-induced memory impairment in mice via Nrf2 and NF-ĸB signaling.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rifat JahanDepartment of Chemistry Islamia College University, Peshawar 25120, Pakistan.ORCID https://orcid.org/0000-0003-2736-8430
Mohammad YousafDepartment of Chemistry Islamia College University, Peshawar 25120, Pakistan.ORCID https://orcid.org/0000-0002-1205-4538
Hamayun KhanDepartment of Chemistry Islamia College University, Peshawar 25120, Pakistan.ORCID https://orcid.org/0000-0002-7116-5940
Nousheen BibiDepartment of Bioinformatics, Shaheed Benazir Bhutto Women University, Peshawar, Pakistan.
Musarrat IjazDepartment of Statistics, Shaheed Benazir Bhutto Women University, Peshawar, Pakistan.
Touseef RehanDepartment of Food and Nutrition, Shaheed Benazir Bhutto Women University, Peshawar, Pakistan.
Shahid Ali ShahNeuro Molecular Medicine Research Center Peshawar, Pakistan.
Shaheed Benazir Bhutto Women University Peshawar · PKIslamia College University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new mechanistic approach to overcome the neurodegenerative disorders caused by oxidative stress in Alzheimer's disease (AD) is highly stressed in this article. Thus, a newly formulated drug (zinc

Indexed as

Alzheimer DiseasePentylenetetrazoleAnimalsAntioxidantsCatalaseDisease Models, AnimalGlutathione TransferaseMaleMiceMolecular Docking SimulationNF-E2-Related Factor 2Oxidative StressProto-Oncogene Proteins c-aktZincAntioxidantsCatalaseGlutathione TransferaseNF-E2-Related Factor 2PentylenetetrazoleProto-Oncogene Proteins c-aktZinc

Identifiers

PMID36193329
PMCPMC9526611
OpenAlexW4296345133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.